Get in touch
Our Client Services team is on hand to help. Please call us at 866.776.5907, Option 3.
This panel is designed to detect key genetic abnormalities associated with B-cell lymphoma, including double-hit (DHL) and triple-hit lymphoma (THL). It includes the following probes:
MYC (8q24)
MYC/IgH/CEN8 t(8;14)
Reflex Scheme:
(1) If MYC/IgH/CEN8 t(8;14) is positive, reflex to test for BCL2 (18q21) and BCL6 (3q27).(2) If MYC (8q24) is positive but MYC/IgH/CEN8 t(8;14) is negative, reflex to test for BCL2 (18q21), BCL6 (3q27), IGK/MYC t(2;8), IGL/MYC t(8;22), and BCL6/MYC t(3;8).
Test Customization: Tech Only clients may order probes individually.
The High-Grade B-Cell Lymphoma Reflex Panel differentiates double-hit or triple-hit lymphomas (which have MYC rearrangements together with BCL2 and/or BCL6 rearrangements) from Burkitt lymphoma or diffuse large B-cell lymphoma. Double-hit and triple-hit lymphomas are difficult to classify morphologically without aid of cytogenetics/FISH or IHC, and are associated with an aggressive course. Testing is indicated when B-cell lymphoma patients experience transformation, relapse, or refractory disease. MYC/IgH/CEN8 will confirm heavy chain rearrangement when MYC is rearranged.
IGK/MYC t(2;8), IGL/MYC t(8;22) and BCL6/MYC t(3;8) studies are useful to further subclassify lymphomas that are positive for MYC gene rearrangements, but negative for the most common IGH/MYC translocation. In addition, when both MYC and BCL6 gene rearrangements are present, but no IGH/MYC translocation is identified, these studies may help to differentiate between the double-hit/triple-hit lymphomas (D/T-HL), which have a poor prognosis, and DLBCL with BCL6/IGH translocation, representing a subset of GC B-cell lymphomas distinct from conventional D/T-HL and with better prognosis (so-called "pseudo-double-hit lymphoma").
This reflex panel may be considered a cost-effective alternative to the High-Grade/Large B-Cell Lymphoma FISH Panel when clinical circumstances allow an additional few days for reflex testing if MYC is rearranged.
Bone Marrow Aspirate: 1-2 mL in sodium heparin tube. EDTA tube is acceptable.
Peripheral Blood: 2-5 mL in sodium heparin tube. EDTA tube is acceptable.
Fresh, Unfixed Tissue: Tissue in RPMI. Bone Marrow/Peripheral Blood Smear or Fresh Tissue Touch Preparation Slides: Minimum 3 slides, labeled with specimen type.
Fluids: Mix in equal parts with RPMI (specimen volume to RPMI ratio of 1:1).
Fixed Cell Suspension: A client-prepared fixed cell suspension is acceptable if received in 3:1 Methanol:Glacial Acetic Acid.
H&E slide (required) plus paraffin block.
Cut Slides: H&E slide (required) plus 4 unstained slides cut at 4-5 microns.
*The CPT codes provided with our test descriptions are based on AMA guidelines and are for informational purposes only. Correct CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payor being billed.
Last Updated: August 27, 2025